Sang-We Kim

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Smoking Cessation

Tyrosine Kinase

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Cancer medicine

Cancer discovery

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jiyun Lee, Hee Kyung Ahn, Sang-We Kim, Ji-Youn Han, Sung Sook Lee, Hyung Soon Park, Hyun Woo Lee, Joo-Hang Kim, Eunhan Cho, Reto Huggenberger, Byoung Chul Cho
Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study. Cancer medicine 13 (7) (2024)
Jiyun Lee, Hee Kyung Ahn, Sang-We Kim, Ji-Youn Han, Sung Sook Lee, Hyung Soon Park, Hyun Woo Lee, Joo-Hang Kim, Eunhan Cho, Reto Huggenberger, Byoung Chul Cho
Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study. Cancer medicine 13 (7) (2024)
Jiyun Lee, Hee Kyung Ahn, Sang-We Kim, Ji-Youn Han, Sung Sook Lee, Hyung Soon Park, Hyun Woo Lee, Joo-Hang Kim, Eunhan Cho, Reto Huggenberger, Byoung Chul Cho
Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study. Cancer medicine 13 (7) (2024)
Ryan J Hartmaier, Aleksandra A Markovets, Myung-Ju Ahn, Lecia V Sequist, Ji-Youn Han, Byoung Chul Cho, Helena Alexandra Yu, Sang-We Kim, James Chih-Hsin Yang, Jong Seok Lee, Wu-Chou Su, Dariusz Mirosław Kowalski, Sergey V Orlov, Song Ren, Paul Frewer, Xiaoling Ou, Darren Ae Cross, Nisha Kurian, Mireille Cantarini, Pasi A Janne
Osimertinib+Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor Mutated MET-Amplified Non-Small Cell Lung Cancer: TATTON. Cancer discovery (2022)
Margarita Majem Tarruella, Jonathan Wade Goldman, Thomas John, Christian Grohe, Konstantin Laktionov, Sang-We Kim, Terufumi Kato, Huu Vinh Vu, Shun Lu, Shanqing Li, Kye Young Lee, Charuwan Akewanlop, Chong-Jen Yu, Filippo de Marinis, Laura Bonanno, Manuel Dómine, Frances A Shepherd, Shinji Atagi, Lingmin Zeng, Dakshayini Kulkarni, Nenad Medic, Masahiro Tsuboi, Roy S Herbst, Yi-Long Wu
Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Jwa Hoon Kim, Seyoung Seo, Jee Hyun Kim, Su-Jin Koh, Yongchel Ahn, Kyung Hae Jung, Jin-Hee Ahn, Sung-Bae Kim, Tae Won Kim, Yong Sang Hong, Sun Young Kim, Jeong Eun Kim, Sang-We Kim, Dae Ho Lee, Jae Cheol Lee, Chang-Min Choi, Shinkyo Yoon, Jae Ho Jeong, Hwa Jung Kim, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Young Joo Min, Jin Ho Baek, Sook Ryun Park
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study. Cancer medicine (2021)
Pasi A Janne, Christina Baik, Wu-Chou Su, Melissa L Johnson, Hidetoshi Hayashi, Makoto Nishio, Dong Wan Kim, Marianna Koczywas, Kathryn A Gold, Conor E Steuer, Haruyasu Murakami, James Chih-Hsin Yang, Sang-We Kim, Michele Vigliotti, Rong Shi, Zhenhao Qi, Yang Qiu, Lihui Zhao, David Sternberg, Channing Yu, Helena A Yu
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer. Cancer discovery (2021)